Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis.
Verkamp B, Zoref-Lorenz A, Francisco B, Kieser P, Mack J, Blackledge T, Brik Simon D, Yacobovich J, Jordan MB. Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis. Blood Adv. 2023 12 12; 7(23):7258-7269.